Want to see AMN full AI Analyst Report?
AMN Stock Chart & Stats
$32.89
$0.56(1.70%)
At close: 4:00 PM EDT
$32.89
$0.56(1.70%)
Day’s Range― - ―
52-Week Range$14.97 - $37.22
Previous Close$33.45
Volume505.79K
Average Volume (3M)897.47K
Market Cap
$1.33B
Enterprise Value$1.68K
Total Cash (Recent Filing)$361.84M
Total Debt (Recent Filing)$775.81M
Price to Earnings (P/E)12.8
Beta0.89
Next Earnings
Oct 29, 2026EPS Estimate
0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.70
Shares Outstanding38,729,992
10 Day Avg. Volume737,862
30 Day Avg. Volume897,474
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.95
Price to Sales (P/S)0.22
P/FCF Ratio2.60
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$36.33Price Target Upside10.47% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)3.29
Revenue Forecast (FY)$3.35B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationAMN's trailing‑twelve‑month operating cash flow (~$471M) and free cash flow (~$455M) demonstrate durable cash conversion that supports debt reduction, selective M&A, and modest buybacks. Reliable cash generation gives management flexibility to invest through cyclical staffing demand swings.
Scale And Clinician NetworkA 400k+ Passport network with rapidly rising monthly active users builds a long‑term sourcing moat, lowering marginal recruiter costs and improving fill rates. Platform scale and digitized clinician engagement support sustainable placement volume growth and competitive differentiation in staffing markets.
Improved Leverage And Cash BufferLeverage has meaningfully improved from earlier highs and TTM metrics show a rebuilt equity base and positive ROE (~15%). Combined with a multi‑hundred million dollar cash balance, the balance sheet provides runway to manage cyclicality and modest strategic investments without immediate covenant strain.
Bears Say
Revenue And Margin VolatilityAMN's historical swings across 2023–2025 and still‑subpar margins versus prior peaks signal persistent cyclicality in staffing demand and pricing. This variability undermines earnings visibility and means multi‑period recovery may be uneven even if topline recovers, complicating capital allocation.
Q2 Nonrecurring Uplift And Guidance NormalizationMaterial one‑time billing accrual true‑ups and reserve reversals boosted Q2 results; management's Q3 guidance expects notably lower adjusted EBITDA margins. Reliance on nonrecurring items to drive near‑term outperformance raises risk that cash and earnings improvements are temporary rather than structural.
Segment Headwinds And Pricing PressureDeclines in Technology & Workforce Solutions, ongoing price compression in language services, and weakness in physician/leadership staffing indicate parts of AMN face secular or competitive pressures. These segment headwinds limit diversification and could cap margin recovery even as nurse staffing strengthens.
AMN Healthcare Services News
AMN FAQ
What was AMN Healthcare’s price range in the past 12 months?
AMN Healthcare lowest stock price was $14.97 and its highest was $37.22 in the past 12 months.
What is AMN Healthcare’s market cap?
AMN Healthcare’s market cap is $1.33B.
When is AMN Healthcare’s upcoming earnings report date?
AMN Healthcare’s upcoming earnings report date is Oct 29, 2026 which is in 67 days.
How were AMN Healthcare’s earnings last quarter?
AMN Healthcare released its earnings results on Aug 06, 2026. The company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.189 by $0.581.
Is AMN Healthcare overvalued?
According to Wall Street analysts AMN Healthcare’s price is currently Undervalued.
Does AMN Healthcare pay dividends?
AMN Healthcare pays a Quarterly dividend of $0.3 which represents an annual dividend yield of N/A. See more information on AMN Healthcare dividends here
What is AMN Healthcare’s EPS estimate?
AMN Healthcare’s EPS estimate is 0.23.
How many shares outstanding does AMN Healthcare have?
AMN Healthcare has 38,729,992 shares outstanding.
What happened to AMN Healthcare’s price movement after its last earnings report?
AMN Healthcare reported an EPS of $0.77 in its last earnings report, beating expectations of $0.189. Following the earnings report the stock price went up 16.883%.
Which hedge fund is a major shareholder of AMN Healthcare?
Currently, no hedge funds are holding shares in AMN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AMN Healthcare Services Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$36.33 (10.47% Upside)
$36.33 (10.47% Upside)
Blogger Sentiment
Bullish
AMN Sentiment 75%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 306.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
68.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.86%
Trailing 12-Months
Company Description
AMN Healthcare
AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.
AMN Company Deck
AMN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial highlights — revenue beat, sizable adjusted EBITDA and EPS improvement, robust cash balance, low leverage, strong Nurse & Allied performance, accelerated travel and allied volumes, and meaningful product adoption and search momentum. Several targeted acquisitions and improved operational automation/AI capabilities support longer-term growth. Offsetting these positives are notable near-term headwinds: Technology & Workforce Solutions and language services revenue declines and pricing pressure, a weaker locum/physician segment, and the fact that the Q2 outperformance was partly driven by nonrecurring items that will not repeat in Q3. Management provided conservative Q3 guidance reflecting normalization. Overall, the company appears well-positioned financially and operationally, with manageable short-term challenges and a constructive outlook into 2027.View all AMN earnings summariesAMN Revenue Breakdown
69.26% Nurse and allied solutions
17.67% Physician and leadership solutions
13.06% Technology and workforce solutions
AMN Stock 12 Month Forecast
Average Price Target
$36.33
▲(10.47% Upside)
Technical Analysis
Addus Homecare
―
Healthcare Services
―
Pediatrix Medical Group
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
0.87% Insiders
23.48% Mutual Funds
16.62% Other Institutional Investors
30.56% Public Companies and
Individual Investors